201 related articles for article (PubMed ID: 5004351)
1. [Specificity of antituberculous action in vitro of pyrazine-2-carboxylic acid derivatives].
Pavlov EP
Probl Tuberk; 1971; 49(7):76-9. PubMed ID: 5004351
[No Abstract] [Full Text] [Related]
2. [Antitubercular properties of some derivatives of pyrazine carboxylic acid].
Solov'ev VN; Pavolo EP
Farmakol Toksikol; 1967; 30(6):734-7. PubMed ID: 4970686
[No Abstract] [Full Text] [Related]
3. [Characteristics of antituberculous action in vitro of pyrazine-2-carboxylic acid derivatives].
Pavlov EP
Probl Tuberk; 1971; 49(7):76-9. PubMed ID: 5005811
[No Abstract] [Full Text] [Related]
4. Evaluation of the BacT/ALERT PZA kit in comparison with the BACTEC 460TB PZA for testing Mycobacterium tuberculosis susceptibility to pyrazinamide.
Aragón LM; Garrigó M; Moreno C; Español M; Coll P
J Antimicrob Chemother; 2007 Sep; 60(3):655-7. PubMed ID: 17615155
[TBL] [Abstract][Full Text] [Related]
5. [Antituberculous action of a new antibiotic, Lividomycin. Effect on experimental tuberculosis of mice and cross resistance with other antituberculous agents].
Tsukamura M; Mizuno S; Yamamoto M
Kekkaku; 1970 Aug; 45(8):263-72. PubMed ID: 4989999
[No Abstract] [Full Text] [Related]
6. Iron enhances the antituberculous activity of pyrazinamide.
Somoskovi A; Wade MM; Sun Z; Zhang Y
J Antimicrob Chemother; 2004 Feb; 53(2):192-6. PubMed ID: 14729751
[TBL] [Abstract][Full Text] [Related]
7. [Determination of Mycobacterium tuberculosis' sensitivity to pyrazinamide on a BACTEC-960 bacteriological analyzer].
Irtuganova OA; Smirnova NS; Slogotskaia LV
Probl Tuberk Bolezn Legk; 2003; (7):40-2. PubMed ID: 12939878
[No Abstract] [Full Text] [Related]
8. Standardisation of sensitivity tests.
Mitchison DA
Int J Tuberc Lung Dis; 1998 Jan; 2(1):69-70. PubMed ID: 9562114
[No Abstract] [Full Text] [Related]
9. Synthesis of pyrazinamide Mannich bases and its antitubercular properties.
Sriram D; Yogeeswari P; Reddy SP
Bioorg Med Chem Lett; 2006 Apr; 16(8):2113-6. PubMed ID: 16464574
[TBL] [Abstract][Full Text] [Related]
10. Effects of weak acids, UV and proton motive force inhibitors on pyrazinamide activity against Mycobacterium tuberculosis in vitro.
Wade MM; Zhang Y
J Antimicrob Chemother; 2006 Nov; 58(5):936-41. PubMed ID: 16950824
[TBL] [Abstract][Full Text] [Related]
11. [Effect of antitubercular agents of the 2d series: ethionamide, ethoxyd cycloserine and pyrazinamide on the development of drug resistance of Mycobacterium tuberculosis to tubazide and phthivazide].
Makeeva OO
Farmakol Toksikol; 1969; 32(2):202-5. PubMed ID: 4977183
[No Abstract] [Full Text] [Related]
12. Higher activity of morphazinamide over pyrazinamide against intracellular.
Teyssier L
Int J Tuberc Lung Dis; 2001 Apr; 5(4):386. PubMed ID: 11334260
[No Abstract] [Full Text] [Related]
13. [Evaluation of the pyrazinamidase test for the detection of susceptibility of Mycobacterium tuberculosis to pyrazinamide].
Montoro Cardoso E; López Novo M; Echemendía Font M; Valdivia Alvarez JA
Rev Cubana Med Trop; 1999; 51(1):53-4. PubMed ID: 10887557
[TBL] [Abstract][Full Text] [Related]
14. Mode of action of pyrazinamide: disruption of Mycobacterium tuberculosis membrane transport and energetics by pyrazinoic acid.
Zhang Y; Wade MM; Scorpio A; Zhang H; Sun Z
J Antimicrob Chemother; 2003 Nov; 52(5):790-5. PubMed ID: 14563891
[TBL] [Abstract][Full Text] [Related]
15. Development and evaluation of a line probe assay for rapid identification of pncA mutations in pyrazinamide-resistant mycobacterium tuberculosis strains.
Sekiguchi J; Nakamura T; Miyoshi-Akiyama T; Kirikae F; Kobayashi I; Augustynowicz-Kopec E; Zwolska Z; Morita K; Suetake T; Yoshida H; Kato S; Mori T; Kirikae T
J Clin Microbiol; 2007 Sep; 45(9):2802-7. PubMed ID: 17596354
[TBL] [Abstract][Full Text] [Related]
16. [Pyrazinamide monoresistant Mycobacterium tuberculosis in Manisa region, Turkey].
Ozkütük N; Ecemiş T; Sürücüoğlu S
Mikrobiyol Bul; 2008 Oct; 42(4):585-90. PubMed ID: 19149079
[TBL] [Abstract][Full Text] [Related]
17. Nitrate reductase assay for the rapid detection of pyrazinamide resistance in Mycobacterium tuberculosis using nicotinamide.
Martin A; Cubillos-Ruiz A; Von Groll A; Del Portillo P; Portaels F; Palomino JC
J Antimicrob Chemother; 2008 Jan; 61(1):123-7. PubMed ID: 17981833
[TBL] [Abstract][Full Text] [Related]
18. Pyrazinamide: a frontline drug used for tuberculosis. Molecular mechanism of action resolved after 50 years?
Kalinda AS; Aldrich CC
ChemMedChem; 2012 Apr; 7(4):558-60. PubMed ID: 22241617
[No Abstract] [Full Text] [Related]
19. A new rapid and simple colorimetric method to detect pyrazinamide resistance in Mycobacterium tuberculosis using nicotinamide.
Martin A; Takiff H; Vandamme P; Swings J; Palomino JC; Portaels F
J Antimicrob Chemother; 2006 Aug; 58(2):327-31. PubMed ID: 16751203
[TBL] [Abstract][Full Text] [Related]
20. pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis clinical isolates from the southeast region of Brazil.
Barco P; Cardoso RF; Hirata RD; Leite CQ; Pandolfi JR; Sato DN; Shikama ML; de Melo FF; Mamizuka EM; Campanerut PA; Hirata MH
J Antimicrob Chemother; 2006 Nov; 58(5):930-5. PubMed ID: 16971417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
